This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
5. References
Menasché P, Hagege AA., Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001; 357: 279–280.
Hagège AA, Carrion C, Menasché P, et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003; 361: 491–492.
Menasché P, Hagège AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41: 1078–1083.
Herreros J, Prosper F, Perez A, et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003; 24: 2012–2020.
Siminiak T, Kalawski R, Fiszer D, et al. Transplantation of autologous skeletal myoblasts in the treatment of patients with postinfarction heart failure. Early results of phase I clinical trial. Circulation 2002; 106(suppl II): II-626 (Abstract).
Smits PC, Geuns RJM, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure. J Am Coll Cardiol 2003; 42: 2063–2069.
Pagani F, DerSimonian R, Zawadska A, et al. Autologous skeletal myoblasts transplanted to ischemia damaged myocardium in humans. J Am Coll Cardiol 2003; 41: 879–888.
Makkar RR, Lill M, Chen PS. Stem cell therapy for myocardial repair: Is it arrhythmogenic ? J Am Coll Cardiol 2003; 42: 2070–2072.
Leobon B, Garcin I, Menasché P, et al. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 2003; 100: 7808–7811.
Reinecke H, Minami E, Poppa V, Murry C. Evidence for fusion between cardiac and skeletal muscle cells. Circulation 2004; 94: 1–5.
Moss AJ, Zareba W, Hall J, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New Engl J Med 2002; 346: 877–883.
Suzuki K, Murtuza B, Beauchamp JR, et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 2004; 18: 1153–1155.
Tambara K, Sakakibara Y, Sakaguchi G, et al. Transplanted skeletal myoblasts can fully replace the infracted myocardium when they survive in the host in large numbers. Circulation 2003; 108(suppl II): II 259–263.
Reinecke H, Murry CE. Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing ? Cardiovasc Pathol. 2000; 9: 337–344.
Ott HC, Bonaros N, Marksteiner R, et al. Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Eur J Cardiothorac Surg 2004; 25: 627–634.
Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-drived factor 1 on stem-cell homing and tissue regeneration in ischemic cardiomyopathy. Lancet 2003; 362: 697–703.
Germani A, Di Carlo A, Mangoni A, et al. Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol 2003; 163: 1417–1428.
Murtuza B, Suzuki K, Bou-Gharios G, et al. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci USA 2004; 101: 4216–4221.
Thomson RB, Emani SM, Davis BH, et al. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Circulation 2003; 108(suppl I): I 264–271.
Agbulut O, Vandervelde S, Al Attar N, et al. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 2004; 44: 458–463.
Yoon YS, Park JS, Tkebuchava T, Luedeman C, Losordo DW. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 2004; 109: 3154–3157.
Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002; 34: 241–249.
Murry CE, Soonpa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664–668.
Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004; 10: 494–501.
Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763–776.
Scorsin M, Hagège AA, Marotte F, et al. Does transplantation of cardiomyocytes improve function of infarcted myocardium ? Circulation 1997; 96[Suppl II]: II 188–193.
Leor J, Patterson M, Quinones MJ, Kedes LH, Kloner RA. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. Circulation 1996; 94[Suppl II]: II 332–336.
Min JY, Yang Y, Sullivan MF, et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 2003; 125: 361–369.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Menasché, P. (2006). Skeletal Myoblasts: The European Experience. In: Dib, N., Taylor, D.A., Diethrich, E.B. (eds) Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair. Springer, Boston, MA. https://doi.org/10.1007/0-387-30939-X_6
Download citation
DOI: https://doi.org/10.1007/0-387-30939-X_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25788-4
Online ISBN: 978-0-387-30939-2
eBook Packages: EngineeringEngineering (R0)